Pharmacology

Action Mechanism of Action Reference
AGONIST Interferon alpha/beta receptor agonist PubMed DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hepatitis B, Chronic 4 D019694 ClinicalTrials
Hepatitis B, Chronic 4 D019694 ClinicalTrials
Primary Myelofibrosis 3 D055728 ClinicalTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 D015464 ClinicalTrials
Hepatitis D 3 D003699 ClinicalTrials
Infections 3 D007239 ClinicalTrials
Hepatitis C 3 D006526 ClinicalTrials
HIV Infections 3 D015658 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Thrombocythemia, Essential 3 D013920 ClinicalTrials
Polycythemia Vera 3 D011087 ClinicalTrials
Liver Cirrhosis 3 D008103 ClinicalTrials
Primary Myelofibrosis 3 D055728 ClinicalTrials
Hepatitis 3 D006505 ClinicalTrials
Depressive Disorder 3 D003866 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Thrombocytopenia 2 D013921 ClinicalTrials
Clostridium Infections 2 D003015 ClinicalTrials
Colonic Neoplasms 2 D003110 ClinicalTrials
Diffuse Intrinsic Pontine Glioma 2 D000080443 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Kidney Neoplasms 1 D007680 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
17.03
Gastrointestinal disorders
10.25
Nervous system disorders
9.25
Skin and subcutaneous tissue disorders
8.78
Investigations
8.67
Psychiatric disorders
7.24
Musculoskeletal and connective tissue disorders
4.76
Respiratory, thoracic and mediastinal disorders
4.57
Blood and lymphatic system disorders
4.37
Vascular disorders
4.18
Injury, poisoning and procedural complications
4.15
Cardiac disorders
3.49
Infections and infestations
3.02
Metabolism and nutrition disorders
2.3

Cross References

Resources Reference
CAS NUMBER 198153-51-4
ChEMBL CHEMBL1201560
FDA SRS Q46947FE7K